标题：Update to U.S. Medical Eligibility Criteria for Contraceptive Use, 2016: Updated Recommendations for the Use of Contraception Among Women at High Risk for HIV Infection
摘要：What is already known about this topic? Prevention of both unintended pregnancy and human immunodeficiency virus (HIV) acquisition is critical among women at high risk for HIV infection. What is added by this report? CDC updated recommendations in the “U.S. Medical Eligibility Criteria for Contraceptive Use” to state that progestin-only injectable contraception (including depot medroxyprogesterone acetate) and intrauterine devices (including levonorgestrel-releasing and copper-bearing) are safe for use without restriction among women at high risk for HIV infection. What are the implications for public health practice? Women at high risk for HIV are eligible to use all hormonal contraceptive methods and intrauterine devices. Recommended HIV infection prevention measures, including preexposure and postexposure prophylaxis, limiting number of sexual partners, and correct and consistent use of condoms, should be strongly encouraged among all women at high risk for HIV acquisition and should be integrated into family planning services.
关键词：Medical Eligibility Criteria For Contraceptive Use;U.S;MEC Contraception;Contraceptive Methods Updated Recommendations;Women At High Risk For HIV And Use Of Contraception;Contraceptive Use Among Women At High Risk For HIV;HIV/AIDS;Contraception;Women's Health;MMWR;Morbidity & Mortality Weekly Report
